BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

  Incyte (Nasdaq:INCY) today reports 2022 third quarter financial results, and provides a status update on the Company’s clinical development portfolio.

  November 1, 2022

   · 

  30 min read
• Drug Development

  HARMONY BIOSCIENCES ANNOUNCES TOPLINE RESULTS FROM PHASE 2 PROOF-OF-CONCEPT STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME

  Topline data show positive signal in treating excessive daytime sleepiness.

  November 1, 2022

   · 

  12 min read
• Business

  Voyager Therapeutics Announces Third Quarter 2022 Conference Call and Webcast

  Voyager Therapeutics, Inc. today announced it will report third quarter 2022 financial and operating results before the market opens on Tuesday, November 8, 2022.

  November 1, 2022

   · 

  1 min read
• Business

  Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

  Repligen Corporation today reported financial results for its third quarter of 2022.

  November 1, 2022

   · 

  22 min read
• Business

  Neurocrine Biosciences Reports Third Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance

  Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2022 and raised net sales guidance for INGREZZA in 2022.

  November 1, 2022

   · 

  15 min read
• Business

  Sage Therapeutics Appoints Laura M. Gault, M.D., Ph.D. as Chief Medical Officer

  Sage Therapeutics today announced the appointment of Laura Gault, MD, Ph.D. as Chief Medical Officer.

  November 1, 2022

   · 

  4 min read
• Genetown

  Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022

  Enveric Biosciences today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.

  November 1, 2022

   · 

  3 min read
• Business

  Karmanos Cancer Institute partners with nation’s top cancer organizations to endorse initiative to increase lung cancer screening in the United States

  The Barbara Ann Karmanos Cancer Institute has partnered with more than 50 cancer organizations across the country to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography scans for those at high risk for lung cancer.

  November 1, 2022

   · 

  4 min read
• Business

  Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022

  Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022.

  November 1, 2022

   · 

  1 min read
• Biotech Beach

  Prometheus Biosciences to Participate at November 2022 Healthcare Conferences

  Prometheus Biosciences, Inc. announced that management will conduct fireside chats at the following healthcare conferences.

  November 1, 2022

   · 

  2 min read